Canada: Report Of The Board Of Review For Siloxane D5 October 25, 2011

Last Updated: November 10 2011
Article by Harry Dahme

The Report to the Minister from the Siloxane D5 Board of Review was released on October 20, 2011. The Report is significant because it flows from the first substantive hearing by a Board of Review established pursuant to the Canadian Environmental Protection Act to review the nature and extent of danger to the environment posed by a chemical.  Siloxane D5 had been proposed to be added to Schedule 1 of the Canadian Environmental Protection Act following the completion of a Screening Assessment conducted by Environment Canada and Health Canada as part of Canada's Chemical Management Plan.  Gowling Lafleur Henderson LLP represented the Silicones Environmental, Health and Safety Council of North America before the Board of Review.


Siloxane D5 is a odourless, colourless liquid that has many consumer and industrial applications. It is used as an ingredient in a number of personal care products, including deodorants, antiperspirants, cosmetics, shampoos and body lotions. It is also used as a dry cleaning solvent and in industrial cleaning.

Pursuant to Section 74 of the Canadian Environmental Protection Act, 1999 ("CEPA 1999"), the Ministers of the Environment and of Health conducted a Screening Assessment of D5. During the categorization process, D5 had been identified as a high priority for a Screening Assessment on the basis that it met the ecological categorization criteria for persistence, bio-accumulation potential and inherent toxicity to non-human organisms, and that it was known to be in commerce in Canada. The Screening Assessment concluded that, based upon the available information on its potential to cause ecological harm, D5 was considered to be entering the environment in a quantity or concentration or under conditions that has or may have an immediate or long-term harmful effect on the environment or its biological diversity. On that basis it was concluded that D5 met one or more of the criteria of Section 64 of CEPA 1999.

A Notice of Objection was filed with supporting information objecting to the conclusion reached in the Screening Assessment and a request was made to establish a Board of Review pursuant to Section 77(8) of CEPA 1999. Based upon the new scientific data provided, the Minister of the Environment agreed that a further inquiry into the nature and extent of the danger posed by D5 was warranted and accordingly established the Board of Review.

Report of the Board of Review

The Board considered all available information about the intrinsic physical and chemical properties of D5, along with its toxicity, uses, exposures and effects.  Based upon the evidence, the Board  concluded that:

  • D5 does not pose a danger to the environment;
  • while D5 may exceed the regulatory threshold for persistence it does not exceed the thresholds established in the Persistence and Bioaccumulation Regulation;
  • D5 does not bio-magnify, although it may bio-accumulate, and
  • there is no evidence to identify that D5 is toxic to any organism tested up to the limit of solubility in any environmental matrix.

Procedural Matters

The Report of the Board of Review summarizes a number of relevant procedural matters to be considered in the event of the establishment of any future Board of Review. These are:

  • the mandate of the Board may be constrained to only consider the extent of danger to the environment, and not human health as a consequence of the decision of the Minister establishing such a Board of Review;
  • the hearing before the Board is a de novo assessment of the available science;
  • the Board's review is not an appeal per se of the Screening Assessment; and
  • there is to be a full exchange of available information prior to commencement of the hearing. In addition to filing of all pertinent scientific data and reports, there was an opportunity to submit interrogatories and file supplementary data and reports in response to interrogatories. In addition, witness statements providing a summary of the evidence to be given by the witness were required to be provided.  As stated in the Report, "as a result before the hearing began, parties and the Board had a comprehensive and extensive record relating to Siloxane D5".

Legislation and Regulations

The mandate of the Board was to determine the scope and extent of the danger to the environment posed by D5. The Board concluded that its mandate was not to conduct an appeal of the Screening Assessment, recognizing that the Board should not ignore the analysis and conclusions expressed in the Screening Assessment. The Board concluded that its mandate did not include a determination on whether D5 was "CEPA-Toxic" according to Section 64 nor whether it should or should not be added to Schedule 1 to CEPA as a toxic substance.

In considering however the nature and extent of the danger posed by D5, the Board interpreted its mandate to mean that it was required to determine whether detrimental effects were caused or might be caused to the environment by D5 taking into account all of the available, relevant, scientific information about D5. Importantly the Board concluded that it was required to take into account "information about the "intrinsic" physical and chemical properties of the substance along with its uses, releases, dissipation, transformation, and degradation, pathways of exposures, toxicity and effects."  Further, the Board concluded that its review should be rooted in real-world terms and should not be a hypothetical assessment based on worst-case scenarios, insofar as the available data did not warrant that manner of proceeding.

The Persistent and Bioaccumulation Regulations were considered by the Board. A critical question addressed by the Board was the extent to which the intrinsic properties of the substance should be considered in assessment of persistence and bioaccumulation. Should the Regulations be interpreted to mean that the intrinsic properties of a substance should only be taken into account in cases where it is not possible to rely on the generally recognized methods of the OECD or other similar organizations when assessing persistence and bioaccumulation? The Board determined that:

"when assessing persistence and bioaccumulations evaluators should take into account the other factors referred to in section 5: the intrinsic properties of a chemical, the ecosystem under consideration, and conditions in the environment. Furthermore, the Board interpreted the term "intrinsic properties" to mean intensive properties such as vapour pressures and solubility as well as extensive properties such as toxicity."

On the issue of bioaccumulation the Board decided that the determination of whether a substance is bio-accumulative is not based solely on the bioaccumulation factor ("BAF"), the bio-concentration factor ("BCF") or the logarithm of its octanol-water partition coefficient ("Kow"), but may take into account other measures of bioaccumulation such as the bio-magnification factor ("BMF"), tropic magnification factor ("TMF") and fugacity. In other words, the values of BAF, BCF or Kow may be used to screen chemicals out from further consideration or to prioritize chemicals for further study but should not be used to determine whether the chemical itself will pose a danger. Rather the Regulations require consideration of the intrinsic properties of the substance as well as other aspects of bioaccumulation.

Last, with respect to the application of the "precautionary principle", the Board determined that the degree to which this principle should be applied depends upon the credibility and trustworthiness of scientific information about the substance.  If there is sufficient credible and trustworthy scientific information to conduct a scientifically robust and meaningful risk assessment then the Board concluded that it did not need to rely solely on the precautionary approach.

Nature, Use, Distribution, Concentrations and Toxicity of D5

Some observations taken from the Report of the Board which may be relevant for the purpose of assessing other substances are set out below.

  • Environment Canada regularly uses models to estimate releases to the environment, as well as the fate and distribution of a substance after release. The Board concluded that these models and tools have limitations and inaccuracies and consequently the interpretations based on the models were of limited use. Where empirical monitoring data is available, greater weight was given to measured values and the estimates provided by the models.
  • Long range transport by itself is an insufficient basis upon which to conclude a substance may pose a danger to the environment. In the case of D5 notwithstanding that D5 can be transported relatively long distances, depositions to soil or water are limited.
  • It is inappropriate to determine that a substances poses danger to the environment based on data from an extreme worst-case scenario, not representative of the concentrations released into the environment in other locations in Canada.
  • Persistence is not necessarily an indicator of danger in and of itself.
  • The Board followed a heirarchical evaluation of bioaccumulation. The Board considered the evidence of BAF and concluded that the values for BAF were equivocal and did not support a conclusion that the regulatory threshold for BAF had been met. The Board considered alternative methods of expressing bio-accumulation including multi-media BAF ("mmBAF") but concluded that it would not be appropriate to rely on either mmBAF or relative BAF. BCF is the second factor to be considered and the Board concluded that the values for BCF were equivocal . The Board went on to consider the biota-sediment accumulation factor ("BSAF"), the BMF and TMF and based upon a review of all of the data, including depuration rates concluded that D5 does not bio-magnify, notwithstanding that it can be accumulated from environmental matrices or food into organisms. Accordingly, the Board rejected the conclusion in the Screening Assessment that D5 should be classed a bio-accumulative simply by comparing the values of BAF and/or BCF to the threshold values in the Regulations. The Board concluded that such an approach may be appropriate in a lower – tiered screening assessment and in the absence of additional information of that intrinsic properties of a substance, but that where there is robust information then a more refined assessment of the potential danger should be conducted.
  • The Board concluded that adverse effects from D5 are only observed in very large concentrations, in excess of solubility limits for the various environmental matrices, which cannot be obtained in the environment as a result of normal release.
  • The Screening Assessment calculated Hazard Quotations for D5. In the Board's opinion, the Hazard Quotations were based on incorrect assumptions and parameters used to predict concentrations in the event resulting in a overly conservative estimate of the risk of D5. The Board rejected that over estimate.
  • The Board prepared probability plots for the purpose of determining danger to plants or animals and concluded that the risks were minimal.

Observations and Recommendations

The Board also made a number of observations and recommendations. These include the following:

  • The Persistence and Bioaccumulation Regulations should be reviewed periodically to ensure that they reflect current scientific standards and risk assessment methodologies.
  • A guidance document should be issued to describe how parameters such as persistence, bioaccumulation and intrinsic properties are to be examined in the risk assessment.
  • The Board encouraged Environment Canada to update its models or tools regularly, to seek outside input to ensure the integrity of those models and to ensure that users are aware of the strengths and weaknesses of the models or tools. The Board recommended that the models become transparent.

Conclusion and Summary

The Board concluded that D5 did not present a risk to the environment. While the Report of the Board may be considered as being restricted to D5, it is useful for the purposes of determining how other substances should be evaluated, how the applicable Regulations should be interpreted, and the kind of information that will be required in the event that there is any dispute with the conclusions reached in a Screening Assessment.

In order to review the Report please see:

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
16 Jan 2018, Seminar, Birmingham, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

23 Jan 2018, Seminar, London, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

25 Jan 2018, Seminar, Birmingham, UK

2018 is set to be another big year in employment, with employers set to face new challenges and responsibilities. At our event, looking ahead to next year, we will be discussing four key issues you might face in 2018, providing useful tips and answering your questions.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions